BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11745201)

  • 41. The expression of thymidine phosphorylase suppresses spontaneous apoptosis of cancer cells in esophageal squamous cell carcinoma.
    Ikeguchi M; Sakatani T; Ueta T; Fukuda K; Yamaguchi K; Tsujitani S; Kaibara N
    Pathobiology; 2001; 69(1):36-43. PubMed ID: 11641616
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Significance of thymidine phosphorylase/platelet-derived endothelial cell growth factor in carcinoma of the papilla of Vater.
    Zhao B; Kimura W; Futakawa N; Abe H; Kitayama J; Nagawa H; Makuuchi M
    Jpn J Cancer Res; 2000 Mar; 91(3):331-6. PubMed ID: 10760693
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of thymidine phosphorylase as an indicator of poor prognosis for patients with transitional cell carcinoma of the bladder.
    Arima J; Imazono Y; Takebayashi Y; Nishiyama K; Shirahama T; Akiba S; Furukawa T; Akiyama S; Ohi Y
    Cancer; 2000 Mar; 88(5):1131-8. PubMed ID: 10699904
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Angiogenic factor thymidine phosphorylase associates with angiogenesis and lymphangiogenesis in the intestinal-type gastric cancer.
    Zhang X; Zheng Z; Shin YK; Kim KY; Rha SY; Noh SH; Chung HC; Jeung HC
    Pathology; 2014 Jun; 46(4):316-24. PubMed ID: 24798152
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Localization of thymidine phosphorylase expression in colorectal carcinoma tissues by in situ RT-PCR assay.
    Mimori K; Matsuyama A; Yoshinaga K; Yamashita K; Masuda T; Inoue H; Ueo H; Mori M
    Oncology; 2002; 62(4):327-32. PubMed ID: 12138240
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of a thymidine phosphorylase inhibitor on angiogenesis and apoptosis in tumors.
    Matsushita S; Nitanda T; Furukawa T; Sumizawa T; Tani A; Nishimoto K; Akiba S; Miyadera K; Fukushima M; Yamada Y; Yoshida H; Kanzaki T; Akiyama S
    Cancer Res; 1999 Apr; 59(8):1911-6. PubMed ID: 10213500
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Expression of thymidine phosphorylase in cancer].
    Jiang LN; Yu SY; Xiong HH; Zhang MX
    Zhonghua Zhong Liu Za Zhi; 2004 May; 26(5):297-9. PubMed ID: 15312368
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Thymidine phosphorylase expression in gallbladder adenocarcinomas.
    Giatromanolaki A; Sivridis E; Simopoulos C; Polychronidis A; Gatter KC; Harris AL; Koukourakis MI
    Int J Surg Pathol; 2002 Jul; 10(3):181-8. PubMed ID: 12232571
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Up-regulation of extracellular signal-regulated kinase 1/2-dependent thymidylate synthase and thymidine phosphorylase contributes to cisplatin resistance in human non-small-cell lung cancer cells.
    Ko JC; Tsai MS; Chiu YF; Weng SH; Kuo YH; Lin YW
    J Pharmacol Exp Ther; 2011 Jul; 338(1):184-94. PubMed ID: 21444628
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevention of hypoxia-induced apoptosis by the angiogenic factor thymidine phosphorylase.
    Kitazono M; Takebayashi Y; Ishitsuka K; Takao S; Tani A; Furukawa T; Miyadera K; Yamada Y; Aikou T; Akiyama S
    Biochem Biophys Res Commun; 1998 Dec; 253(3):797-803. PubMed ID: 9918807
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factors.
    Brown NS; Jones A; Fujiyama C; Harris AL; Bicknell R
    Cancer Res; 2000 Nov; 60(22):6298-302. PubMed ID: 11103787
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of thymidine phosphorylase in the induction of early growth response protein-1 and thrombospondin-1 by 5-fluorouracil in human cancer carcinoma cells.
    Matsushita S; Ikeda R; Nishizawa Y; Che XF; Furukawa T; Miyadera K; Tabata S; Ushiyama M; Tajitsu Y; Yamamoto M; Takeda Y; Minami K; Mataki H; Kanzaki T; Yamada K; Kanekura T; Akiyama S
    Int J Oncol; 2010 May; 36(5):1193-200. PubMed ID: 20372793
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thymidine phosphorylase and breast carcinoma.
    Yang Q; Yoshimura G; Mori I; Sakurai T; Kakudo K
    Anticancer Res; 2002; 22(4):2355-60. PubMed ID: 12174926
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human bladder cancer.
    Tanaka T; Yoshiki T; Arai Y; Higuchi K; Kageyama S; Ogawa Y; Isono T; Okada Y
    Jpn J Cancer Res; 1999 Dec; 90(12):1344-50. PubMed ID: 10665652
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Infiltration of thymidine phosphorylase-positive macrophages is closely associated with tumor angiogenesis and survival in intestinal type gastric cancer.
    Kawahara A; Hattori S; Akiba J; Nakashima K; Taira T; Watari K; Hosoi F; Uba M; Basaki Y; Koufuji K; Shirouzu K; Akiyama S; Kuwano M; Kage M; Ono M
    Oncol Rep; 2010 Aug; 24(2):405-15. PubMed ID: 20596627
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Targeting platelet-derived endothelial cell growth factor/thymidine phosphorylase for cancer therapy.
    Liekens S; Bronckaers A; Pérez-Pérez MJ; Balzarini J
    Biochem Pharmacol; 2007 Dec; 74(11):1555-67. PubMed ID: 17572389
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Angiogenesis in pancreatic carcinoma: thymidine phosphorylase expression in stromal cells and intratumoral microvessel density as independent predictors of overall and relapse-free survival.
    Fujioka S; Yoshida K; Yanagisawa S; Kawakami M; Aoki T; Yamazaki Y
    Cancer; 2001 Oct; 92(7):1788-97. PubMed ID: 11745251
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Overexpression of the angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase in psoriatic epidermis.
    Creamer D; Jaggar R; Allen M; Bicknell R; Barker J
    Br J Dermatol; 1997 Dec; 137(6):851-5. PubMed ID: 9470899
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The angiogenic factor thymidine phosphorylase up-regulates the cell adhesion molecule P-selectin in human vascular endothelial cells and is associated with P-selectin expression in breast cancers.
    Gunningham SP; Currie MJ; Morrin HR; Tan EY; Turley H; Dachs GU; Watson AI; Frampton C; Robinson BA; Fox SB
    J Pathol; 2007 Jul; 212(3):335-44. PubMed ID: 17487938
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy.
    Gasparini G; Toi M; Miceli R; Vermeulen PB; Dittadi R; Biganzoli E; Morabito A; Fanelli M; Gatti C; Suzuki H; Tominaga T; Dirix LY; Gion M
    Cancer J Sci Am; 1999; 5(2):101-11. PubMed ID: 10198732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.